Search Results - "Nashed, Jeannette"

FDA Approval Summary: Dabrafenib in Combination with Trametinib for BRAFV600E Mutation-Positive Low-Grade Glioma by Barbato, Michael I, Nashed, Jeannette, Bradford, Diana, Ren, Yi, Khasar, Sachia, Miller, Claudia P, Zolnik, Banu S, Zhao, Hong, Li, Yangbing, Bi, Youwei, Shord, Stacy S, Amatya, Anup K, Mishra-Kalyani, Pallavi S, Scepura, Barbara, Al-Matari, Raniya A, Pazdur, Richard, Kluetz, Paul G, Donoghue, Martha, Singh, Harpreet, Drezner, Nicole

“…On March 16, 2023, the FDA approved dabrafenib in combination with trametinib (Tafinlar, Mekinist; Novartis Pharmaceuticals Corporation) for the treatment of…”
Get full text

FDA Approval Summary: Dabrafenib in Combination with Trametinib for BRAF V600E Mutation–Positive Low-Grade Glioma by Barbato, Michael I., Nashed, Jeannette, Bradford, Diana, Ren, Yi, Khasar, Sachia, Miller, Claudia P., Zolnik, Banu S., Zhao, Hong, Li, Yangbing, Bi, Youwei, Shord, Stacy S., Amatya, Anup K., Mishra-Kalyani, Pallavi S., Scepura, Barbara, Al-Matari, Raniya A., Pazdur, Richard, Kluetz, Paul G., Donoghue, Martha, Singh, Harpreet, Drezner, Nicole

“…Abstract On March 16, 2023, the FDA approved dabrafenib in combination with trametinib (Tafinlar, Mekinist; Novartis Pharmaceuticals Corporation) for the…”
Get full text

Phase 1 Study of Alvelestat, an Oral Neutrophil Elastase Inhibitor, in Patients with Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation by Im, Annie, Holtzman, Noa G., Curtis, Lauren M., Parsons-Wandell, Laura, Nashed, Jeannette, Peer, Cody, Figg, William D., Barochia, Amisha, Rose, Jeremy J., Hakim, Frances T., Pavletic, Steven Z.

“…Introduction Bronchiolitis Obliterans Syndrome (BOS) is a rare but devastating complication of chronic graft-versus-host disease (GVHD) after allogeneic…”
Get full text

Efficacy and Safety of Baricitinib in Refractory Chronic Graft-Versus-Host Disease (cGVHD): Preliminary Analysis Results of a Phase 1/2 Study by Holtzman, Noa G., Im, Annie, Ostojic, Alen, Curtis, Lauren M., Parsons-Wandell, Laura, Nashed, Jeannette, Peer, Cody, Figg, William D., Magone, M. Teresa, Cowen, Edward W, Mays, Jacqueline W, Hakim, Frances T., Rose, Jeremy J., Pouzelles, Marie C, Taylor, Naomi, Pavletic, Steven Z.

“…Background: Chronic Graft-versus-Host Disease (cGVHD) is a multi-organ disorder characterized by immune dysregulation, impaired organ function, and decreased…”
Get full text

Factors Associated with Subsequent Cancers in Patients with Moderate or Severe Chronic Graft-Versus-Host Disease after Transplant for Hematologic Malignancy by Schaar, Dana, Pirsl, Filip, Steinberg, Seth M., Parsons-Wandell, Laura, Emanuel, Michael, Flucker, Shaneil, Nashed, Jeannette, Ruben, Claire, Curtis, Lauren M., Cowen, Edward W, Mays, Jacqueline, Munshi, Pashna N., Im, Annie, Berger, Ann, Joe, Galen O, Datiles, Manuel B, Pavletic, Steven Z.

“…Among patients who survive over two years post-allo-HSCT, cGVHD and subsequent cancers represent a significant source of morbidity and mortality. Long-term…”
Get full text

Subsequent Cancers in Patients Affected with Moderate or Severe Chronic Graft-versus-Host Disease by Schaar, Dana A., Pirsl, Filip, Holtzman, Noa, Steinberg, Seth M., Nashed, Jeannette, Ruben, Claire, Cowen, Edward W., Mays, Jacqueline W., Mitchell, Sandra, Ostojic, Alen, Munshi, Pashna N., Joe, Galen O., Comis, Leora E., Morton, Lindsay, Pavletic, Steven Z.

“…•The 10-year cumulative incidence of nonmelanoma skin cancer (NMSC) was 15.5% (95% confidence interval [CI], 9.0% to 27.6%).•The 10-year cumulative incidence…”
Get full text